Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Amortization of Deferred Charges (2021 - 2025)

Nephros (NEPH) has 8 years of Amortization of Deferred Charges data on record, last reported at $22000.0 in Q3 2025.

  • For Q3 2025, Amortization of Deferred Charges rose 4.76% year-over-year to $22000.0; the TTM value through Sep 2025 reached $88000.0, down 19.27%, while the annual FY2024 figure was $91000.0, 48.0% down from the prior year.
  • Amortization of Deferred Charges reached $22000.0 in Q3 2025 per NEPH's latest filing, up from $20000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $75000.0 in Q1 2022 and bottomed at $20000.0 in Q2 2025.
  • Average Amortization of Deferred Charges over 5 years is $41705.9, with a median of $44000.0 recorded in 2022.
  • Peak YoY movement for Amortization of Deferred Charges: skyrocketed 54.35% in 2022, then plummeted 54.35% in 2024.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $74000.0 in 2021, then crashed by 40.54% to $44000.0 in 2022, then fell by 6.82% to $41000.0 in 2023, then plummeted by 43.9% to $23000.0 in 2024, then dropped by 4.35% to $22000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Amortization of Deferred Charges were $22000.0 in Q3 2025, $20000.0 in Q2 2025, and $23000.0 in Q1 2025.